LVMH considers selling some underperforming assets to cope with weak demand
Source: Global Market Report
According to sources familiar with the matter, French luxury giant LVMH is considering selling some of its fashion, beauty, and alcohol brands, in what could be one of the largest retrenchment moves in its nearly 40-year history, as a response to sluggish demand.
Sources say the businesses LVMH plans to sell include the fashion brand Marc Jacobs, its stake in singer Rihanna's beauty brand Fenty Beauty, and American wine producer Joseph Phelps Vineyards.
These potential deals could bring the group billions of euros in capital for reinvestment in its business, not including a recent series of asset disposals.
Over the past 18 months, LVMH has already sold the luxury streetwear brand Off-White created by the late designer Virgil Abloh, the Greater China business of travel retailer DFS, and its 49% stake in the Stella McCartney eponymous fashion brand.
LVMH owns over 75 brands, spanning high fashion, cognac, hotels, newspapers, and more. Selling these underperforming businesses is part of its cost-control strategy.
The group is refocusing on major profit-driving brands such as Louis Vuitton and Dior. Since 2023, as the luxury market boom during the pandemic reversed, sales of these brands have slowed. The so-called "aspirational" consumers have less disposable income, and the ongoing price hikes by top brands, surpassing inflation, together have dampened market demand.
Bernstein analyst Luca Solca said, “LVMH is clearly reviewing its portfolio, looking at what is underperforming and what is dragging down margin, because they are in a period of greater business pressure.”
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
U.S. non-farm payrolls surge by 165,000 in October, far exceeding expectations! Unemployment rate unexpectedly drops to 4.1%, December rate hike expectations intensify
In October, US non-farm payrolls increased by 165,000, which is 2.5 times the Wall Street median forecast of 65,000 and represents an exceptionally strong deviation of about 5 standard deviations, exceeding the upper limit of all institutional forecast ranges. The unemployment rate unexpectedly fell from 4.2% to 4.1%, while the market had expected it to remain unchanged; average hourly wages also accelerated year-on-year growth to 3.1%. Meanwhile, the previous two months' non-farm payrolls were revised upwards by a total of 84,000. Following the release of the data, the yield on 2-year US Treasury bonds rose by 7 basis points, and the pricing of the probability of a Fed rate hike in December climbed to 70%.
AI Sell-off Hits Anthropic IPO, Potential Valuation Expected to Drop to $1.2–1.3 Trillion
The valuation range discussed by potential investors has been lowered from the previous high of $2 trillion to between $1.2 trillion and $1.3 trillion, and some strategists have even suggested going below $1 trillion to ensure safety. In the face of significant market volatility and financial concerns such as quarterly losses, Anthropic is facing tough decisions, including a discounted valuation, reducing the size of the offering, or postponing the listing.
Moderna Q3 revenue up 29% year-on-year, far exceeding expectations, raises full-year revenue growth guidance to 15%-25% | Earnings Report Insight
Moderna's Q3 revenue increased by 29% year-on-year to $1.31 billion, with profits significantly exceeding expectations. The company raised its 2026 revenue growth guidance to 15%-25%. The ramp-up of next-generation COVID-19 and flu vaccines, along with international market expansion, has driven performance improvement. Phase III data for the personalized cancer vaccine has also shown positive progress. The company is simultaneously advancing cost reduction and pipeline R&D, with year-end cash expectations significantly raised.
Crypto prices
More
